Pancreatic endocrine tumors: An update

Advances in Anatomic Pathology

Volumn 11, Issue 4, 2004, Pages 202-210

  Chetty, Runjan ^a   Asa, Sylvia L ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Chromosomal abnormalities; Endocrine tumor; MEN 1; Pancreas; Von Hippel Lindau disease

Indexed keywords

ADULT; ENDOCRINE TUMOR; HUMAN; PANCREAS TUMOR; REVIEW;

ADULT; ENDOCRINE GLAND NEOPLASMS; HUMANS; PANCREATIC NEOPLASMS;

EID: 16544375606     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/01.pap.0000131828.00189.29     Document Type: Review

References (60)

1. Lack EE. Pathology of the pancreas, gallbladder, extrahepatic biliary tract, and ampullary region. In Pancreatic Endocrine Neoplasms. New York: Oxford University Press; 2003:323-373.
2. Lubensky I. Endocrine pancreas. In: LiVolsi VA, Asa SL, eds: Endocrine Pathology. Philadelphia: Churchill Livingstone; 2002:205-236.
3. Kloppel G, IntVeld PA, Komminoth P, et al. The endocrine pancreas. In: Kovacs K, Asa SL, eds. Functional Endocrine Pathology, 2nd ed. Cambridge: Blackwell Scientific Publications; 1998:415-487.
4. Gumbs AA, Moore PS, Falconi M, et al. Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms. J Surg Oncol. 2002;81:45-53. (Pubitemid 34983166)
5. Grimelius L, Hultquist GT, Stenkvist B. Cytological differentiation of asymptomatic pancreatic islet cell tumors in autopsy material. Virchows Arch. 1975;365:275-288.
6. Kimura W, Kuroda A, Morioka Y. Clinical pathology of endocrine tumors of the pancreas. Dig Dis Sci. 1991;36:933-942.
7. Wick MR, Graeme-Cook FM. Pancreatic neuroendocrine neoplasms. A current summary of diagnostic, prognostic, and differential diagnostic information. Am J Clin Pathol. 2001;115:S28-S45.
8. Lam KY, Lo CY. Pancreatic endocrine tumour: a 22-year clinicopathological experience with morphological, immunohistochemical observation and a review of the literature. Eur J Surg Oncol. 1997;23:36-42. (Pubitemid 27107490)
9. Owen DA, Kelly JK. Pathology of the gallbladder, biliary tract and pancreas. Major problems in Pathology, vol 39. Philadelphia: WB Saunders Co; 2001.
10. Mullan MH, Gauger PG, Thompson NW. Endocrine tumours of the pancreas: review and recent advances. ANZ J Surg. 2001;71:475-482. (Pubitemid 32868553)
11. Legaspi A, Brennan M. Management of islet cell carcinoma. Surgery. 1988;104:1018-1023. (Pubitemid 19011981)
12. Lo CY, van Heerden JA, Thompson GB, et al. islet cell carcinoma of the pancreas. World J Surg. 1996;20:878-883.
13. Dial P, Braasch J, Rossi R, et al. Management of non functioning islet cell tumors of the pancreas. Surg Clin North Am. 1985;65:291-299. (Pubitemid 15246022)
14. Falconi M, Bonora A, Bassi C, et al. Non-functioning pancreatic tumours. In: Dervenis C, Bassi C, eds. Pancreatic tumours, Achievements and Prospective. Stuttgart: Georg Thieme Verlag; 2000:345-52.
15. Cheslyn-Curtis S, Sitaram V, Williamson RCN. Management of non-functioning neuroendocrine tumours of the pancreas. Br J Surg. 1993;80:625-627. (Pubitemid 23167250)
16. Bonner-Weir S, Baxter LA, Schuppin GT, et al. A second pathway for regeneration of adult exocrine and endocrine pancreas. Diabetes. 1993;42:1715-1720.
17. Rindi G. Transgenic models of endocrine tumours. In: Polak JM, ed. Diagnostic Histopathology of Neuroendocrine Tumours. Edinburgh: Churchill-Livingstone; 1993:67-89.
18. Smith FE, Rosen KM, Villa-Komaroff L, et al. Enhanced insulin-like growth factor I gene expression in regenerating rat pancreas. Proc Natl Acad Sci USA. 1991;61:6152-6156. (Pubitemid 21914904)
19. La Rosa S, Furlan D, Sessa F, et al. The endocrine pancreas. In: Lloyd RV, ed. Endocrine Pathology. Differential Diagnosis and Molecular Advances. New Jersey: Humana Press; 2004:291-328.
20. Chetty R. Potpourri of pancreatic and periampullary pathology. Curr Diagn Pathol. 2000;6:165-170.
21. Laidlaw GF. Nesidioblastoma, the islet cell tumor of the pancreas. Am J Pathol. 1938;14:125-134.
22. Liu MH, Potter EL. Development of the human pancreas. Arch Pathol. 1962;74:439-452.
23. Solcia E, Kloppel G, Sobin LH, et al. Histological Typing of Endocrine Tumours. WHO International Histological Classification of Tumours, 2nd ed. Berlin: Springer; 2000.
24. Wick MR. Neuroendocrine neoplasia: current concepts. Am J Clin Pathol. 2000;113:331-335. (Pubitemid 30217378)
25. Trump D, Farren B, Wooding C, et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN I). Q J Med. 1996;89:653-669. (Pubitemid 26319017)
26. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276:404-407.
27. Burgess JR, Greenaway TM, Shepherd JJ. Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. J Intern Med. 1999;243:465-470.
28. Jensen RT. Pancreatic endocrine tumors: recent advances. Ann Oncol. 1999;10:S170-S176. (Pubitemid 29333425)
29. Friedrich CA. Von Hippel-Lindau syndrome. A pleomorphic condition. Cancer. 1999;86:2478-2482. (Pubitemid 30007530)
30. Hough MT, Stephens DH, Johnson CD, et al. Pancreatic lesions in von Hippel-Lindau disease: prevalence clinical significance, and CT findings. Am J Roentgenol. 1994;162:1091-1094. (Pubitemid 24144976)
31. Lubensky IA, Pack S, Ault D, et al. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease. Am J Pathol. 1998;153:223-231.
32. Neumann HPH, Dinkel E, Brambs H, et al. Pancreatic lesions in the von Hippel-Lindau syndrome. Gastroenterology. 1991;101:465-471.
33. Binkovitz LA, Johnson CD, Stephens DH. Islet cell tumors in von Hippel-Lindau disease: increased prevalence and relationship to the multiple endocrine neoplasias. Am J Roentgenol. 1990;155:501-505. (Pubitemid 20254489)
34. Hammel PR, Vilgrain V, Terris B, et al. Pancreatic involvement in von Hippel-Lindau disease. Gastroenterology. 2000;119:1087-1095.
35. Libutti SK, Choyke PL, Bartlett DL, et al. Pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease: diagnostic and management recommendations. Surgery. 1998;124:1153-1159. (Pubitemid 28555208)
36. Chetty R, Kennedy M, Ezzat S, et al. Pancreatic neuroendocrine pathology in a patient with Von Hippel-Lindau disease: An expanding spectrum of lesions. Endocrine Pathology (in press).
37. Verhoef S, van Diemen-Steenvoorde R, Akkersdijk WL, et al. Malignant pancreatic tumor within the spectrum of tuberous sclerosis complex in childhood. Eur J Pediatr. 1999;158:284-287. (Pubitemid 29183702)
38. Francalanci P, Diomedi-Camassei F, Purifacto C, et al. Malignant pancreatic endocrine tumor in a child with tuberous sclerosis. Am J Surg Pathol. 2003;27:1386-1389. (Pubitemid 37185831)
39. Guo SS, Sawaicli MP. Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type 1. Mol Endocrinol. 2001;15:1653-1664. (Pubitemid 32939297)
40. Calender A, Vercherat C, Gaudray P, et al. Deregulation of genetic pathways in neuroendocrine tumors. Ann Oncol. 2001;12:S3-S11. (Pubitemid 33069680)
41. Hessman O, Skogseid B, Westin G, et al. Multiple allelic deletions and intratumoral genetic heterogeneity in MEN 1 pancreatic tumors. J Clin Endocrinol Metab. 2001;86:1355-1361. (Pubitemid 32323028)
42. Moore PS, Missiaglia E, Antonello D, et al. Role of disease-causing genes in sporadic pancreatic endocrine tumors: MEN 1 and VHL. Genes Chromosome Cancer. 2001;32:177-181.
43. Rigaud G, Missiaglia E, Moore PS, et al. High resolution allelotype of nonfunctional pancreatic endocrine tumors: Identification of two molecular subgroups with clinical implications. Cancer Res. 2001;61:285-292. (Pubitemid 32095729)
44. Speel EJ, Richter J, Moch H, et al. Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization. Am J Pathol. 1999;155:1787-1794.
45. Hessman O, Lindberg D, Skogseid B, et al. Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas. Cancer Res. 1998;58:377-379. (Pubitemid 28087391)
46. Shan L, Nakamura M, Yokoi T, et al. Somatic mutations of multiple endocrine neoplasia type 1 gene in the sporadic endocrine tumors. Lab Invest. 1998;78:471-475. (Pubitemid 28207859)
47. Zhuang Z, Vortmeyer AO, Pack S, et al. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res. 1997;57:4682-4686. (Pubitemid 27468966)
48. Debelenko LV, Zhuang Z, Emmert-Buck MR, et al. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res. 1997;57:2238-2243. (Pubitemid 27247044)
49. Cupisti K, Hoppner W, Dotzenrath C, et al. Lack of MEN1 gene mutations in 27 sporadic insulinomas. Eur J Clin Invest. 2000;30:325-329. (Pubitemid 30234861)
50. Gortz B, Roth J, Krahenmann A, et al. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. Am J Pathol. 1999;154:429-436. (Pubitemid 29094093)
51. Chung DC, Smith AP, Louis DN, et al. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications. J Clin Invest. 1997;100:404-410. (Pubitemid 27349088)
52. Pavelic K, Hrascan R, Kapitanovic S, et al. Molecular genetics of malignant insulinoma. Anticancer Res. 1996;16:1707-1717. (Pubitemid 26270672)
53. Pavelic K, Hrascan R, Kapitanovic S, et al. Multiple genetic alterations in malignant metastatic insulinomas. J Pathol. 1995;177:395-400.
54. Yoshimoto K, Iwahana H, Fukuda A, et al. Ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism. Jpn J Cancer Res. 1992;83:1057-1062.
55. Beghelli S, Pelosi G, Zamboni G, et al. Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p. J Pathol. 1998;186:41-50. (Pubitemid 28407487)
56. Yashiro T, Fulton N, Hara H, et al. Comparisons of mutations of ras oncogene in human pancreatic exocrine and endocrine tumors. Surgery. 1993;114:758-764. (Pubitemid 23303326)
57. Muscarella P, Melvin WS, Fisher WE, et al. Genetic alterations in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors: an analysis of p16/MTS1 tumor suppressor gene inactivation. Cancer Res. 1998;58:237-240. (Pubitemid 28047061)
58. Moore PS, Rigaud G, Zamboni G, et al. Pancreatic tumors: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Br J Cancer. 2001;84:253-262. (Pubitemid 32113454)
59. Bartsch DK, Kersting M, Wild A, et al. Low frequency of p16 (INK4a) alterations in insulinomas. Digestion. 2000;62:171-177.
60. Perren A, Komminoth P, Saremaslani P, et al. Mutation and expression analyses reveal different subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am J Pathol. 2000;157:1097-1103.